|
RAD50 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.081600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.244100E-02 |
| Normal-vs-Stage2 |
1.907370E-01 |
| Normal-vs-Stage3 |
2.548000E-01 |
| Normal-vs-Stage4 |
3.132400E-01 |
| Stage1-vs-Stage2 |
6.723800E-01 |
| Stage1-vs-Stage3 |
5.064000E-03 |
| Stage1-vs-Stage4 |
1.496480E-02 |
| Stage2-vs-Stage3 |
6.314400E-02 |
| Stage2-vs-Stage4 |
7.263800E-02 |
| Stage3-vs-Stage4 |
9.944200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.483400E-01 |
| Normal-vs-AfricanAmerican |
3.201600E-02 |
| Normal-vs-Asian |
6.890400E-01 |
| Caucasian-vs-AfricanAmerican |
1.844480E-03 |
| Caucasian-vs-Asian |
9.807400E-01 |
| AfricanAmerican-vs-Asian |
2.204000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.200200E-01 |
| Normal-vs-Female |
2.701400E-01 |
| Male-vs-Female |
4.770400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.142200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.276770E-01 |
| Normal-vs-Age(61-80Yrs) |
7.917400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.905000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.699660E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.464750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.086600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.815610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.356600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.583400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.119200E-01 |
| Normal-vs-Grade 2 |
3.162500E-02 |
| Normal-vs-Grade 3 |
6.879600E-01 |
| Normal-vs-Grade 4 |
1.235820E-02 |
| Grade 1-vs-Grade 2 |
8.842200E-01 |
| Grade 1-vs-Grade 3 |
3.776400E-01 |
| Grade 1-vs-Grade 4 |
2.817800E-02 |
| Grade 2-vs-Grade 3 |
6.940400E-02 |
| Grade 2-vs-Grade 4 |
4.31960000000231E-05 |
| Grade 3-vs-Grade 4 |
5.475300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.23830000000747E-05 |
| Normal-vs-ccB subtype |
1.434990E-01 |
| ccA subtype-vs-ccB subtype |
1.19870000037103E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.714200E-01 |
| Normal-vs-N1 |
4.585400E-01 |
| N0-vs-N1 |
2.908600E-01 |
|
|
